Impact of introduction of noninvasive prenatal testing on uptake of genetic testing in fetuses with central nervous system anomalies.

MLA

Al Toukhi, Samar, et al. “Impact of Introduction of Noninvasive Prenatal Testing on Uptake of Genetic Testing in Fetuses with Central Nervous System Anomalies.” Prenatal Diagnosis, vol. 39, no. 7, June 2019, pp. 544–48. EBSCOhost, https://doi.org/10.1002/pd.5466.

APA

Al Toukhi, S., Chitayat, D., Keunen, J., Roifman, M., Seaward, G., Windrim, R., Ryan, G., & Van Mieghem, T. (2019). Impact of introduction of noninvasive prenatal testing on uptake of genetic testing in fetuses with central nervous system anomalies. Prenatal Diagnosis, 39(7), 544–548. https://doi.org/10.1002/pd.5466

Chicago

Al Toukhi, Samar, David Chitayat, Johannes Keunen, Maian Roifman, Gareth Seaward, Rory Windrim, Greg Ryan, and Tim Van Mieghem. 2019. “Impact of Introduction of Noninvasive Prenatal Testing on Uptake of Genetic Testing in Fetuses with Central Nervous System Anomalies.” Prenatal Diagnosis 39 (7): 544–48. doi:10.1002/pd.5466.